services:
Executive level strategic and operational consulting in the pharma and biotech industries, including:
- Organizational solutions to improve productivity of global health outcomes and pharmacoeconomic organizations.
- Design of market access capability in global organizations.
- Development and commercial program planning to secure pricing, reimbursement and access in global markets.
- Pricing and reimbursement milestones and considerations during deal-making.
- Strategic opportunity assessment for products in early development.
- Integration of safety and value strategies to expand the product evidence base.
- Identification of strategic data needs during development.
- Development of global market access strategies for orphan drugs.
- Leveraging benefit risk information to accelerate product uptake.
- Strategies for effectively communicating value information to health care executives, investment professionals, and the media.
- Strategies for managing parallel trade implications.
- Executive training on pricing, reimbursement and access requirements in worldwide markets.